BIOQUAL, Inc. CFO Announces Retirement and Appointment to BIOQUAL Board
BIOQUAL, Inc. announces the retirement of CFO Dave Newcomer, effective June 3, 2022, after serving since 1994. He will remain to aid in the transition to his successor, Charles (Chris) C. Kirk, Jr., who has over 25 years of financial experience. Newcomer will also join the Board of Directors following his retirement to utilize his company knowledge. This leadership transition emphasizes continuity as BIOQUAL addresses market challenges, including government contracts and demand for animal models in research.
- Charles (Chris) C. Kirk, Jr. appointed as new CFO, bringing 25 years of experience.
- Dave Newcomer will join the Board of Directors post-retirement, ensuring knowledge continuity.
- Risks related to the continuation of government contracts.
- Dependence on demand for animal models in scientific research may affect future performance.
“Dave has been with
Upon his announcement,
Mr. Newcomer’s position will be filled by Mr.
Forward Looking Information
Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and one should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005974/en/
www.bioqual.com
Source:
FAQ
Who is the new CFO of BIOQUAL, Inc.?
What is the effective date of Dave Newcomer's retirement?
What role will Dave Newcomer have after retiring from CFO?
What experience does the new CFO bring to BIOQUAL, Inc.?